Department of Developmental, Chemical and Molecular Biology, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA 02111, USA; Raymond & Beverly Sackler Convergence Laboratory, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA 02111, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Cell Rep. 2019 Sep 24;28(13):3435-3449.e5. doi: 10.1016/j.celrep.2019.08.060.
Comprehensive sequencing approaches have allowed for the identification of the most frequent contributors to cancer, known as drivers. They have also revealed a class of mutations in understudied, infrequently altered genes, referred to as "long tail" (LT) drivers. A key challenge has been to find clinically relevant LT drivers and to understand how they cooperate to drive disease. Here, we identified far upstream binding protein 1 (FUBP1) as an LT driver using an in vivo CRISPR screen. FUBP1 cooperates with other tumor suppressor genes to transform mammary epithelial cells by disrupting cellular differentiation and tissue architecture. Mechanistically, FUBP1 participates in regulating N-methyladenosine (mA) RNA methylation, and its loss leads to global changes in RNA splicing and widespread expression of aberrant driver isoforms. These findings suggest that somatic alteration of a single gene involved in RNA splicing and mA methylation can produce the necessary panoply of contributors for neoplastic transformation.
综合测序方法已经能够鉴定出导致癌症的最常见因素,这些因素被称为驱动因素。它们还揭示了一类在研究较少、很少发生改变的基因中的突变,被称为“长尾”(LT)驱动因素。一个关键的挑战是找到临床上相关的 LT 驱动因素,并了解它们如何合作驱动疾病。在这里,我们使用体内 CRISPR 筛选鉴定了远上游结合蛋白 1(FUBP1)作为 LT 驱动因素。FUBP1 通过破坏细胞分化和组织结构与其他肿瘤抑制基因合作,转化乳腺上皮细胞。从机制上讲,FUBP1 参与调节 N6-甲基腺苷(m6A)RNA 甲基化,其缺失导致 RNA 剪接的全局变化和广泛表达异常的驱动异构体。这些发现表明,参与 RNA 剪接和 m6A 甲基化的单个基因的体细胞改变可以产生肿瘤转化所需的全套贡献因素。